Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235.
暂无分享，去创建一个
N. Munshi | D. McMillin | Jake E. Delmore | P. Richardson | C. Mitsiades | C. García-echeverría | J. Jakubikova | M. Ooi | J. Negri | S. Maira | R. Schlossman | Douglas W. McMillin | P. Hayden | K. Anderson | N. Mitsiades